Keyphrases
Receptor Tyrosine Kinase
100%
Tyrosine Phosphorylation
100%
ACK1
100%
Androgen Receptor
100%
Prostate Cancer Progression
100%
Activated Cdc42-associated Kinase
100%
Androgens
50%
Androgen-independent
35%
Prostate Cancer
28%
Heregulin
21%
Tyrosine
14%
Tyrosine Kinase
14%
Receptor-interacting Protein Kinase 1 (RIPK1)
14%
Receptor Recruitment
14%
Tumor
7%
Tumor Samples
7%
Knockdown
7%
Gene Expression
7%
Signaling Mechanism
7%
Prostate
7%
Human Epidermal Growth Factor Receptor 2 (HER2)
7%
Point mutant
7%
Prostate Cancer Cells
7%
Prostate Tumor
7%
Transcriptional Activity
7%
Activation Domain
7%
Cdc42
7%
Benign Prostate Disease
7%
Multiple Mechanisms
7%
Activation Receptor
7%
Androgen Signaling
7%
Potential Therapeutic Strategies
7%
Oncogenic Mechanisms
7%
Xenograft Tumor
7%
LNCaP
7%
Xenograft Tumor Growth
7%
Inducible Gene Expression
7%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Growth
100%
Phosphotransferase
100%
Protein Phosphorylation
100%
Androgen Receptor
100%
Androgen
80%
Enhancer Region
20%
Neu Differentiation Factor
20%
Protein Tyrosine Kinase
13%
Gene Expression
13%
Receptor Protein
13%
Neoplasm
6%
Cancer Cell
6%
Xenograft
6%
Tumor Progression
6%
Prostate Tumor
6%
Tumor Xenograft
6%
Transactivation
6%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Phosphotransferase
100%
Tyrosine Phosphorylation
100%
Androgen Receptor
100%
Enhancer Region
20%
Tyrosine
20%
Gene Expression
13%
Cancer Cell
6%
Tumor Progression
6%
Receptor Tyrosine Kinase
6%
Tyrosine Kinase
6%
Transactivation
6%
LNCaP
6%
Neuroscience
Kinase
100%
Protein Phosphorylation
100%
Androgen Receptor
100%
Androgen
80%
Enhancer Region
20%
Neu Differentiation Factor
20%
Gene Expression
13%
Receptor Protein
13%
Prostate
13%
Receptor Tyrosine Kinase
6%
Tyrosine Kinase
6%
Transactivation
6%